Standard grade is estimated at 39.0% of product type revenue in 2026, anti-aging at 24.0% of function revenue, and facial skincare at 38.0% of application revenue. Adoption depends on reproducible vesicle characterization and claim support because variable extraction and incomplete stability data can keep actives in evaluation.